InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: Itchy palm post# 201395

Tuesday, 01/25/2022 7:17:59 PM

Tuesday, January 25, 2022 7:17:59 PM

Post# of 232454
This makes me think that the SEC focused on Nadder and not the company. The SEC may have communicated concerns the maybe Nadder was over enthusiastic in some of his statements. If this results in a much better CEO with Pharmaceutical experience and signals the end of the SEC investigation in regards to CytoDyn it would be a double positive.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News